Why the study?
Does fenoldopam mesylate reduce blood pressure in pediatric patients undergoing surgery requiring deliberate hypotension?
Does fenoldopam mesylate reduce blood pressure in pediatric patients undergoing surgery requiring deliberate hypotension?
Fenoldopam is an effective agent for intravenous blood pressure control in children undergoing surgery, though requiring higher doses (0.8-1.2 mcg/kg/min) than adults.
No takes yet. Share an insight, caveat, or question.
Supports fenoldopam for deliberate hypotension in pediatric surgery; extends adult evidence to children at higher doses.
Hammer et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: